Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine

by Romain-David Seban, Laurence Champion, Nicolas Deleval, Capucine Richard, Claire Provost
Published 2021-04-01

Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CT

by Romain-David Seban, Camille Vermersch, Laurence Champion, Benjamin Bonsang, Anissa Roger, Jerome Ghidaglia
Published 2021-04-01

¹⁸F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab

by Romain-David Seban, Anne Donnadieu, Gabrielle Journo, Francois-Clement Bidard, Capucine Richard, Roman Rouzier, Laurence Champion
Published 2021-07-01

The Role of Cost-Effectiveness Analysis in Patient-Centered Cancer Care in the Era of Precision Medicine

by Fabrizio Toscano, Alberto Vera, Eleanor Kim, Davide Golinelli, Helena Vila-Reyes, Fernand Bteich, Antoine Schernberg, Romain-David Seban, Randy Yeh, Laurent Dercle
Published 2021-08-01

Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy

by Romain-David Seban, Charlotte Robert, Laurent Dercle, Randy Yeh, Ariane Dunant, Sylvain Reuze, Antoine Schernberg, Roger Sun, Fabien Mignot, Marie Terroir, Martin Schlumberger, Christine Haie-Meder, Cyrus Chargari, Eric Deutsch
Published 2019-05-01

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab

by Romain-David Seban, Jean-Baptiste Assié, Etienne Giroux-Leprieur, Marie-Ange Massiani, Michael Soussan, Gérald Bonardel, Christos Chouaid, Margot Playe, Lucas Goldfarb, Boris Duchemann, Laura Mezquita, Nicolas Girard, Laurence Champion
Published 2020-08-01